Human growth hormone products are prescription treatments authorised for specific medical conditions. For adult growth hormone deficiency, clinical guidance states that confirmation through stimulation testing is usually required unless particular genetic, structural or pituitary-disease criteria apply.
HGH is not intended as a general anti-ageing, bodybuilding, weight-loss or athletic-performance treatment for otherwise healthy adults.
This article explains why HGH injections may be prescribed, who may qualify for treatment, how adult growth hormone deficiency is diagnosed, and which benefits and side effects may occur. It also outlines how therapy is monitored to support safe and effective care.
What Are HGH Injections and How Do They Work?
People researching HGH injections for sale may encounter several branded somatropin and long-acting growth hormone products. However, these products are not interchangeable, and their approved indications, delivery devices, dosing schedules and availability can differ.
Growth hormone acts directly on several tissues and also stimulates the production of insulin-like growth factor 1, or IGF-1, in the liver and other tissues. Together, these pathways influence metabolism, body composition, bone health and tissue growth.
Because peptide hormones are broken down in the digestive system, approved growth-hormone products are administered by injection, most commonly under the skin. Depending on the product, the medication may be supplied in injection pens, cartridges, prefilled devices or vials requiring preparation.
Who May Be Eligible for HGH Injections?
Eligibility for HGH treatment is limited to patients with an appropriate medical diagnosis. Treatment is not prescribed solely because an adult experiences fatigue, weight gain, low mood or reduced muscle strength.
These symptoms are nonspecific and can result from many medical, psychological or lifestyle factors. They require proper evaluation before growth hormone deficiency is considered.
Symptoms and Risk Factors That May Justify Testing
Adults with growth hormone deficiency may experience reduced energy, increased abdominal fat, reduced lean body mass and lower exercise capacity. Other possible features include reduced bone density, changes in cholesterol levels and impaired quality of life.
However, symptoms alone cannot confirm the condition.
Clinicians are more likely to investigate adult growth hormone deficiency when recognised risk factors are present. These include:
- Pituitary tumours or other pituitary disease
- Previous pituitary surgery
- Radiation involving the brain or pituitary gland
- Damage to the hypothalamus
- Childhood-onset growth hormone deficiency requiring reassessment
- Deficiencies involving other pituitary hormones
Traumatic brain injury is also a recognised risk factor for acquired pituitary dysfunction, including growth hormone deficiency. Reported prevalence varies according to injury severity, timing of assessment and the diagnostic tests used.
How Adult Growth Hormone Deficiency Is Confirmed
Confirming adult growth hormone deficiency requires a multi-step clinical assessment. Diagnosis normally begins with a detailed medical history, assessment of symptoms and review of relevant risk factors.
Clinicians may test IGF-1 and other pituitary hormones and order pituitary imaging when clinically appropriate.
A random growth hormone blood test is usually insufficient because growth hormone is released in pulses throughout the day and night. Levels may be very low or undetectable between pulses, even in people without a deficiency.
For this reason, diagnosis commonly requires a growth hormone stimulation test. This test evaluates whether the pituitary gland can produce an appropriate response after receiving a stimulating agent.
Formal stimulation testing may not be required in certain patients with congenital or genetic growth hormone deficiency or multiple other pituitary hormone deficiencies caused by established organic disease. Whether testing can be omitted should be determined by an endocrinologist using the patient’s medical history, laboratory results and applicable diagnostic criteria.
What Are HGH Injections Used for in Adults?
Treatment depends on the diagnosis and the specific product prescribed.
Adult Growth Hormone Deficiency
Adult growth hormone deficiency may begin during childhood or develop later because of pituitary or hypothalamic disease, surgery, radiation or injury.
Prescribed therapy aims to replace inadequate hormone production rather than raise growth hormone above normal physiological levels. Adult dosing is generally lower than paediatric dosing and is adjusted according to clinical response, side effects and IGF-1 levels.
Other Product-Specific Uses
Certain somatropin products have additional approved indications. For example, Serostim is used for HIV-associated wasting or cachexia, while Zorbtive is used for short bowel syndrome in patients receiving specialised nutritional support.
These approvals are product-specific and should not be assumed to apply to every somatropin brand.
Uses HGH Is Not Routinely Recommended For
Prescription HGH should not be presented as a routine solution for:
- Normal ageing
- General tiredness
- Cosmetic weight loss
- Bodybuilding
- Athletic enhancement
- Muscle gain in healthy adults
It does not reverse ageing or guarantee fat loss, strength gains or improved appearance.
Potential Benefits for Confirmed Growth Hormone Deficiency
For patients with confirmed deficiency receiving medically supervised treatment, potential benefits may include improvements in body composition, exercise capacity, skeletal health and some quality-of-life measures.
Benefits vary among patients, may develop gradually and are most clearly established in people with more severe deficiency. Treatment does not guarantee the same response for every patient.
Side Effects of HGH Injections
Adverse effects depend on the dose, the patient’s age, underlying health conditions and individual response.
Common or Dose-Related Side Effects
Possible side effects include:
- Fluid retention
- Swelling in the hands or feet
- Joint discomfort
- Muscle pain
- Headaches
- Injection-site reactions
- Tingling or numbness
- Carpal tunnel symptoms
- Changes in blood-glucose control
Some effects improve after the prescriber reduces or adjusts the dose. Patients should not change their dose independently.
Symptoms Requiring Medical Attention
Seek emergency assistance for difficulty breathing, facial or throat swelling, or other signs of a severe allergic reaction.
Severe or persistent headaches, vision changes, repeated vomiting, substantial swelling, persistent abdominal pain, neurological symptoms or major changes in blood-glucose control require prompt medical assessment.
Patients should follow the product-specific safety instructions provided by their clinician and pharmacist.
Who Should Avoid or Delay HGH Treatment?
Product-specific contraindications commonly include:
- Active malignancy
- Acute critical illness following complications of major surgery
- Multiple trauma
- Acute respiratory failure
- Severe hypersensitivity to the product
- Active proliferative or severe non-proliferative diabetic retinopathy
Diabetes, thyroid disease, previous tumours, pregnancy, breastfeeding and a history or symptoms of intracranial hypertension require individual assessment and monitoring rather than being universal contraindications.
Patients should disclose their full medical history and current medications and review the prescribing information for the exact product they receive.
How HGH Therapy Is Monitored
Ongoing monitoring evaluates clinical response, IGF-1 levels and adverse effects to determine whether treatment should continue or be adjusted.
Early Follow-Up and Dose Adjustment
Clinicians may consider the patient’s age, sex, symptoms, side effects, IGF-1 response, existing conditions and other hormone treatments when adjusting the dose.
Treatment is individualised and should not be copied from another patient.
Longer-Term Monitoring
Monitoring commonly includes:
- Clinical response
- Side effects
- IGF-1 concentrations
Depending on the patient’s risk factors and treatment plan, clinicians may also assess:
- Fasting blood glucose or HbA1c
- Thyroid function
- Cholesterol and lipid levels
- Body composition
- Bone health
- Other pituitary hormones
- Injection-site problems
Not every test is required at every visit. The follow-up schedule depends on the patient, diagnosis and prescribed product.
When Treatment May Need Adjustment
A clinician may reconsider treatment when:
- Side effects become difficult to manage
- IGF-1 falls outside the intended range
- Blood-glucose control worsens
- Meaningful benefits are not observed
- A new contraindication develops
- The patient changes products or injection devices
Daily vs Weekly HGH Injections
Traditional somatropin replacement products are commonly administered daily.
Somapacitan, a long-acting growth hormone analogue, is available as a once-weekly injection for adults with growth hormone deficiency. Daily and weekly products have different dosing, titration, storage and IGF-1 monitoring instructions.
A less frequent injection is not automatically the best option for every patient. Daily and long-acting products should not be interchanged without guidance from the treating clinician.
Accessing Prescribed HGH Injections Safely
HGH products are prescription medicines rather than ordinary retail products. Patients should obtain them only through an appropriately licensed pharmacy and under the supervision of a qualified healthcare professional.
Patients should use a properly licensed pharmacy that:
- Requires a valid prescription
- Provides access to a licensed pharmacist
- Supplies the exact product selected by the treating clinician
- Provides clear labelling and expiration information
- Follows applicable dispensing and storage requirements
Sellers offering HGH without a prescription or promoting it for bodybuilding, anti-ageing or athletic enhancement should be avoided.
Patients should seek medical advice before switching brands, suppliers, injection devices or treatment schedules.
Safe Storage and Handling
Follow the storage instructions for the exact product, including refrigeration requirements. Avoid excessive heat and do not freeze the medication unless the manufacturer’s instructions specifically permit it.
Always:
- Check the expiration date
- Inspect the packaging and solution
- Use the correct injection device
- Never share pens, cartridges, syringes, needles or vials
- Dispose of used needles in an appropriate sharps container
- Follow product-specific travel instructions
Storage requirements differ among brands and formulations.
Questions to Ask Before Starting HGH Therapy
Discuss questions such as:
- What evidence confirms my diagnosis?
- Do I need a stimulation test?
- What outcomes should I realistically expect?
- Which formulation and device are appropriate?
- Which side effects should I report?
- How often will IGF-1 and blood glucose be checked?
- Could treatment affect my other hormones or medicines?
- What should I do if I miss a dose?
- When should treatment be adjusted or discontinued?
- What should I do before switching products or pharmacies?
Key Takeaways
HGH injections are prescription treatments for defined medical conditions. Symptoms alone do not establish adult growth hormone deficiency, and diagnosis commonly requires clinical assessment, IGF-1 testing, stimulation testing and evaluation of pituitary function.
Potential benefits must be balanced against side effects and contraindications. Treatment should be individualised, obtained through a licensed pharmacy and monitored by a qualified clinician.
Consult an appropriate healthcare professional before starting, changing or stopping growth hormone therapy.
